Wholesale of pharmaceutical and medical goods
NOBEL BIOCARE NORGE AS
Revenue 2024
NOK 29.8m
Operating profit
NOK 805,000
Equity
NOK 8.0m
Incorporated
2004
Share capital
NOK 100,000
Key figures · 2024
Current ratio
0.55
Equity ratio
25.4%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 2.7% | |
| Net margin (%%) | -0.8% | |
| Return on assets (%%) | 2.5% | |
| Likviditet | ||
| Current ratio | 0.55 | |
| Working capital | −10.7m | |
| Soliditet | ||
| Equity ratio (%%) | 25.4% | |
| Debt-to-equity ratio | 2.94 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.